Using kallikrein-related peptidases (KLK) as novel cancer biomarkers

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-01-0026
Issue:2009: 101/2 (Feb) pp. 217-412
Pages:222-224

Using kallikrein-related peptidases (KLK) as novel cancer biomarkers

Manfred Schmitt; Viktor Magdolen
Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universitaet Muenchen, Munich, Germany

DOI

http://dx.doi.org/10.1160/TH09-01-0026

Articles

You've 192 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...